The certification follows an on-site inspection conducted from 18 February to 20 February 2025. It was a full GMP inspection ...

The “Oral Solid Dosage Contract Manufacturing Market: Distribution by Type of Finished Dosage Form (Tablets, Capsules, Granules, Powders and Others), Type of Packaging (Blisters, Sachets ...

Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws. The acquisition ...

Scale-up of the CDMO segment in FY26, is expected to contribute meaningfully to revenue growth and margin expansion, aided by ...

(RTTNews) - Hikma Pharmaceuticals (HIK, HIK.L) has agreed with Xellia Pharmaceuticals to acquire parts of its US finished dosage form business and assets, including a commercial portfolio and ...

Laurus Labs shares rose over 2% in Monday's trading, marking three days of gains. In June 2025, the stock has gained 18%, ...

Global Oral Solid Dosage Manufacturing Market to 2035: by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area and Key Geographical Regions - ...

The “Oral Solid Dosage Contract Manufacturing Market: Distribution by Type of Finished Dosage Form (Tablets, Capsules, Granules, Powders and Others), Type of Packaging (Blisters, Sachets, Inhalers, ...